Argent BioPharma (formerly MGC Pharmaceuticals) is dedicated to meeting unmet medical needs by combining PolyPharmacology and Nanotechnology, aspiring to be a renowned global leader in the biopharmaceutical sector.
The company listed on the ASX in December 2015, following a reverse takeover of Erin Resources.